VEA
KZR

Virtus ETF Advisers’s Kezar Life Sciences KZR Stock Holding History

Virtus ETF Advisers’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,404
Closed -$43.9K – 462
2023
Q1 		$43.9K Sell
1,404
-539
-28% -$31.2K 0.02% 433
2022
Q4 		$137K Sell
1,943
-271
-12% -$20.1K 0.07% 374
2022
Q3 		$191K Buy
2,214
+17
+0.8% +$1.65K 0.08% 324
2022
Q2 		$182K Buy
2,197
+943
+75% +$83.2K 0.07% 313
2022
Q1 		$208K Sell
1,254
-75
-6% -$10.8K 0.09% 196
2021
Q4 		$222K Buy
+1,329
New +$150K 0.08% 195
2021
Q2 		– Sell
-5,431
Closed -$324K – 401
2021
Q1 		$324K Buy
5,431
+96
+2% +$5.61K 0.14% 225
2020
Q4 		$278K Sell
5,335
-1,034
-16% -$57.5K 0.12% 251
2020
Q3 		$308K Sell
6,369
-869
-12% -$41.6K 0.16% 215
2020
Q2 		$375K Buy
+7,238
New +$365K 0.18% 225

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Virtus ETF Advisers's KZR Position: Q2 2023 in Review

Virtus ETF Advisers sold out of Kezar Life Sciences (KZR) in Q2 2023, closing a stake of 1,404 shares — an estimated $43.9K sold.

Virtus ETF Advisers first reported a position in KZR in Q2 2020 and held it in 10 quarters. The position peaked at $375K in Q2 2020. 104 funds tracked by Wall St. Rank hold KZR as of Q2 2023.

  • Virtus ETF Advisers reported no remaining Kezar Life Sciences position as of Q2 2023 after selling out during the quarter.
  • Virtus ETF Advisers sold 1,404 Kezar Life Sciences shares in Q2 2023, an estimated $43.9K.
  • Virtus ETF Advisers first reported a position in Kezar Life Sciences in Q2 2020 and held it in 10 quarters.
  • Virtus ETF Advisers's Kezar Life Sciences position peaked at $375K in Q2 2020.
  • 104 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2023.

Based on Virtus ETF Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.